Načítá se...
A stochastically curtailed two-arm randomised phase II trial design for binary outcomes
Randomised controlled trials are considered the gold standard in trial design. However, phase II oncology trials with a binary outcome are often single-arm. Although a number of reasons exist for choosing a single-arm trial, the primary reason is that single-arm designs require fewer participants th...
Uloženo v:
| Vydáno v: | Pharm Stat |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7612167/ https://ncbi.nlm.nih.gov/pubmed/32860470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.2067 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|